Browse > Article
http://dx.doi.org/10.7586/jkbns.2017.19.3.131

Risk Factors of Dyslipidemia and Related Factors of Medication Adherence in Korea Adults: KNHANES 2013-2015  

Jeon, Mi Yang (College of Nursing.Institute of Health Science.Gyeongsang National University)
Choi, Won Hee (Department of Nursing, Kyungsung University)
Seo, Yeong Mi (Department of Nursing, Gyeongnam National University of Science and Technology)
Publication Information
Journal of Korean Biological Nursing Science / v.19, no.3, 2017 , pp. 131-140 More about this Journal
Abstract
Purpose: Dyslipidemia was a known risk factor for cardiovascular disease and was a leading cause of mortality in worldwide. This study aimed to determine the factors associated with prevalence and medication treatment of dyslipidemia in Korean adult population. Methods: In this study, based on the criteria set by the Korean Society of Lipidology and Atherosclerosis, the factors associated with prevalence and medication treatment of dyslipidemia was evaluated in a population of 12,506 people ($age{\geq}20$), who participated in the Korean National Health and Nutrition Examination Survey (2013-2015). The findings were tested by using multivariate logistic regression. Results: Dyslipidemia prevalence rate was 36.5%. Among populations with dyslipidemia, 17.5% were treated with lipid-lowering drugs. In the multivariate logistic regression model, male, increase in age, lower education level, non-drinker, current smoking, less physical activity, increase of body mass index, hypertension, and diabetes were associated with an increased odd of dyslipidemia. Female, increase in age, higher income, excess fat intake, hypertension, diabetes, myocardial infarction, and angina were associated with an increased odd of medication treat. Conclusion: The results of this study could be used to screen patients at the high risk for dyslipidemia or to predict medication adherence.
Keywords
Cholesterol; Prevalence; Risk factors; Medication adherence;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 World Health Organization. Global Health Observatory (GHO) data. Deaths from NCDs [Internet]. Geneva: World Health Organization; 2012[cited 2015 May 19]. Available from: http://www.who.int/gho/ncd/mortality_morbidity/ncd_total/en/index.html.
2 Kim HC. 2016 Epidemiology of dyslipidemia in Korea. Journal of Korean Medical Association. 2016;59(5):352-357. https://doi.org/10.5124/jkma.2016.59.5.352   DOI
3 Toth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006. Journal of Clinical Lipidology. 2012;6(4):325-30. http://dx.doi:10.1016/j.jacl.2012.05.002   DOI
4 Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Search for Health and Disease : dyslipidemia[Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2013[cited 2016 Mar 17]. Available from: http://health.mw.go.kr/HealthInfoArea/HealthInfo/View.do? idx=160&subIdx=2.
5 Korean Society of Lipidology and Atherosclerosis Dyslipidemia. Dyslipidemia fact sheet in Korea 2015[Internet]. Seoul: Korean Society of Lipidology and Atherosclerosis Dyslipidemia; 2015[cited 2015 Dec 8]. Available from: http://www.lipid.or.kr/.
6 Lee SH, Seomun GA. Investigation of healthy life practices among Korean males and females in relation to dyslipidemia using data from the 2012 Korea National Health and Nutrition Examination Survey. Journal of Digital Convergence. 2016;14(1):327-338. http://dx.doi.org/10.14400/JDC.2016.14.1.327   DOI
7 Committee for Guidelines for Management of Dyslipidemia. 2015 Korean guidelines for management of dyslipidemia. Journal of Lipid and Atherosclerosis. 2015;4(1):61-92.http://dx.doi.org/10.12997/jla.2015.4.1.61   DOI
8 Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. American association of clinical endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocrine Practice. 2012;18(supplement 1):1-78. https://doi.org/10.4158/ep.18.s1.1   DOI
9 Lee KS, Park CY, Meng KH, Bush A, Lee SH, Lee WC, et al. The association of cigarette smoking and alcohol consumption with other cardiovascular risk factors in men from Seoul, Korea. Annals of Epidemiology. 1998;8(1):31-38. https://doi.org/10.1016/s1047-2797(97)00113-0   DOI
10 Choi YS, Lee NH, Cho SH, Park WH, Song KE. Plasma lipid and antioxidant vitamin status in patients with acute myocardial infarction. Korean Journal of Lipidology. 1988:8(1);38-47.
11 Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: a systematic review and meta-analysis. Annals of Pharmacotherapy. 2010;44(9):1410-1421. https://doi.org/10.1345/aph.1P150   DOI
12 Maningat P, Gordon BR, Breslow JL. How do we improve patient compliance and adherence to long-term statin therapy? Current Atherosclerosis Reports. 2013;15(1):291. http://dx.doi.org/10.1007/s11883-012-0291-7   DOI
13 Jang SG, Lee JS. Prevalence and management of dyslipidemia among Korean adults: KNHANES 2010-2012. Journal of the Korea Academia-Industrial Cooperation Society. 2015;16(11):7978-7989. http://dx.doi.org/10.5762/KAIS. 2015.16.11.7978   DOI
14 Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2014: Korea National Health and Nutrition Examination Survey (KNHANES VI-2)[Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2015[cited 2015 Dec 8]. Available from: http://knhanes.cdc.go.kr
15 Cho EJ, Moon KJ. Related factors of medication adherence in patients with dyslipidemia: The 2010-2012 Korean National Health and Nutrition Examination Survey. Korean Journal of Health Education Promotion. 2015;32(2):65-74. http://dx.doi.org/10.14367/kjhep.2015.32.2.65   DOI
16 Ghandehari H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. American Heart Journal. 2008;156:112-119. http://dx.doi.org/10.1016/j.ahj.2008.03.005   DOI
17 Ministry of Health and Welfare. The Korean Nutrition Society, Dietary Reference Intakes for Koreans 2015[Internet]. Sejong: Ministry of Health and Welfare; 2015[cited 2015 Dec 8]. Available from: http://www.korea.kr/archive/expDocView.do?docId=36782.
18 Rodriguez CJ, Daviglus ML, Swett K, González HM, Gallo LC, Wassertheil-Smoller S, et al. Dyslipidemia patterns among Hispanics/Latinos of diverse background in the United States. American Journal of Medicine. 2014;127(12): 1186-1194. https://doi.org/10.1016/j.amjmed.2014.07.026   DOI
19 Korea Centers for Disease Control and Prevention. The Sixth Korea National Health and Nutrition Survey (KNHANES VI)[Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2013-2015[cited 2015 Dec 8]. Available from: http://knhanes.cdc.go.kr/
20 Roh E, Ko SH, Kwon HS., Kim NH, Kim JH, Kim CS, et al. Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010. Diabetes and Metabolism Journal. 2013;37(6):433-449. http://dx.doi.org/10.4093/dmj.2013.37.6.433   DOI
21 Ebrahimi H, Emamian MH, Hashemi H, Fotouhi A. Dyslipidemia and its risk factors among urban middle-aged Iranians: A population-based study. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2016;10(3):149-156. http://dx.doi.org/10.1016/j.dsx.2016.01.009   DOI
22 Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine. 2008;34(1-3):36-51. https://doi.org/10.1007/s12020-008-9100-z   DOI
23 Glanz K, Rimer B, Viswanath K. Health behavior and health education. 4th. SanFrancisco: Jossey-Bass; 2008. p. 592.
24 Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J, Toutouza M, Papaioannou I, et al. Effects of chronic alcohol consumption on lipid levels, inflammatory and haemostatic factors in the general population: the 'ATTICA' Study. European Journal of Cardiovascular Prevention and Rehabilitation. 2003; 10(5):355-361. https://doi.org/10.1097/01.hjr.0000065928.57001.4d   DOI
25 Katsiki N, Al-Rasadi K, Mikhailidis DP. Lipoprotein (a) and cardiovascular risk: The show must go on. Current Medicinal Chemistry. 2017;24(10):989-1006. https://doi.org/10.2174/0929867324666170112111948   DOI
26 Kato T, Inoue T, Morooka T, Yoshimoto N, Node K. Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers. Canadian Journal of Physiology and Pharmacology. 2006;84(5):523-529. https://doi.org/10.1139/y06-030   DOI
27 Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. American Journal of Clinical Nutrition. 2000;71(2):412-433.   DOI
28 Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. Journal of Family Practice. 2000;49(2): 147-152.
29 Warren JR, Falster MO, Fox D, Jorm L. Factors influencing adherence in long-term use of statins. Pharmacoepidemiology and Drug Safety. 2013;22(12): 1298-1307. https://doi.org/10.1002/pds.3526   DOI
30 Mann DM, Allegrante JP, Natarajan S, Halm EA, Charlson M. Predictors of adherence to statins for primary prevention. Cardiovascular Drugs and Therapy. 2007;21(4):311-316. https://doi.org/10.1007/s10557-007-6040-4   DOI